uso de um anticorpo anti-cd20 afucosilado, composição e método de tratamento de paciente que sofre de câncer

摘要

The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with an anti-VEGF antibody for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and an anti-VEGF antibody.